Ironwood Pharmaceuticals IRWD
NASDAQ IRWD
$4.87 +0.06 (+1.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Ironwood Pharmaceuticals (IRWD) Research & Development (2009 - 2026)

Updated

Ironwood Pharmaceuticals (IRWD) posted Research & Development of $22.42 million for Q2 2026, down 4.1% from $23.37 million a year earlier but up 2.2% from the prior quarter.

Analysis

Ironwood Pharmaceuticals (IRWD) Research & Development (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Ironwood Pharmaceuticals was $88.69 million, down 16.3% year-over-year; for FY2025, it came in at $95.14 million, down 14.6% from FY2024.

  • Annual Research & Development shows a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
  • In prior years, Ironwood Pharmaceuticals' Research & Development was $111.42 million in FY2024 (-4.0%), $116.09 million in FY2023 (+162.3%), $44.27 million in FY2022 (-37.1%) and $70.41 million in FY2021 (-20.1%).
  • Quarterly Research & Development has run from a low of $10.45 million in Q4 2022 to a high of $35.68 million in Q4 2023 over five years.
  • On a year-over-year basis, Research & Development has declined in each of the last five quarters, with an average decline of 14.7% over the last eight quarters.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q4 2023, with growth of 241.5%; the weakest was Q4 2022, with a decline of 67.2%.
  • According to Business Quant data, Research & Development for the three prior quarters was $21.94 million (Q1 2026), $21.86 million (Q4 2025) and $22.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 4.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.57 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.89 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.61 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.02 Bn
10 Ironwood Pharmaceuticals 796.30 Mn 194.87 Mn - 28.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 28.35 Mn
Jun 30, 2026 22.42 Mn
Mar 31, 2026 21.94 Mn
Dec 31, 2025 21.86 Mn
Sep 30, 2025 22.47 Mn
Jun 30, 2025 23.37 Mn
Mar 31, 2025 27.43 Mn
Dec 31, 2024 25.39 Mn
Sep 30, 2024 29.83 Mn
Jun 30, 2024 30.39 Mn
Mar 31, 2024 25.82 Mn
Dec 31, 2023 35.68 Mn
Sep 30, 2023 32.99 Mn
Jun 30, 2023 34.58 Mn
Mar 31, 2023 12.85 Mn
Dec 31, 2022 10.45 Mn
Sep 30, 2022 11.55 Mn
Jun 30, 2022 11.45 Mn
Mar 31, 2022 10.82 Mn
Dec 31, 2021 31.85 Mn
API Access

Ironwood Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=IRWD&period=max&api_key=YOUR_API_KEY